key: cord-0746909-gehqnskj
authors: Spoto, Silvia; Agrò, Felice E.; Sambuco, Federica; Travaglino, Francesco; Valeriani, Emanuele; Fogolari, Marta; Mangiacapra, Fabio; Costantino, Sebastiano; Ciccozzi, Massimo; Angeletti, Silvia
title: High value of Mid‐regional proAdrenomedullin in COVID‐19: a marker of widespread endothelial damage, disease severity and mortality.
date: 2020-11-17
journal: J Med Virol
DOI: 10.1002/jmv.26676
sha: 68fcc942c42035d53ad07d6efe4dd55831f0f9ec
doc_id: 746909
cord_uid: gehqnskj

The widespread endothelial damage due to severe acute respiratory syndrome Coronavirus 2 (SARS‐CoV2) may lead to a disruption of the adrenomedullin (ADM) system responsible for vascular leakage, increased inflammatory status, and microvascular alteration with multi‐organs dysfunction. The aim of this study was to evaluate the role of Mid‐regional proAdrenomedullin (MR‐proADM) as a marker of SARS CoV2‐related widespread endothelial damage, clinically identified by organs damage, disease severity and mortality. Patients with SARS‐CoV2 infection has been prospectively enrolled and demographic characteristic, clinical and laboratory data has been evaluated. In the overall population, 58% developed acute respiratory distress syndrome (ARDS), 23.3% of patients died, 6.5% acute cardiac injury, 1.4% of patients developed acute ischemic stroke, 21.2% acute kidney injury, 11.8% acute liver damage, and 5.4% septic shock. The best MR‐proADM cut‐off values for ARDS development and mortality prediction were 3.04 nmol/L and 2 nmol/L, respectively. Patients presenting with MR‐proADM values ≥ 2 nmol/L showed a significantly higher mortality risk. In conclusion, MR‐proADM values ≥ 2 nmol/l identify those patients with high mortality risk related to a multiorgan dysfunction syndrome. These patients must be carefully evaluated and considered for an intensive therapeutic approach. This article is protected by copyright. All rights reserved.

The Coronavirus disease 2019 , caused by the severe acute respiratory distress syndrome Coronavirus 2 (SARS-CoV2), was responsible for an unprecedent threat to global health. (1) The clinical manifestations of the disease range from asymptomatic cases to severe pneumonia with high mortality rates (4 to 13%), mainly in the case of acute respiratory distress syndrome (ARDS) development. (2) Trying to stratify disease severity, the World Health Organization classified patients in four classes (mild to critical) basing on clinical and radiological characteristics. ( 3) The use of biomarkers, however, may help clinicians identifying those patients with a severe disease and a higher risk of death. (4, 5) Up to date, no markers of endothelial damage in COVID-19 have been validated in clinical practice.

Adrenomedullin (ADM), a 6 kDa protein with a 22 minutes half-life, is produced by endothelial and vascular smooth muscle cells due to volume overload to maintain endothelial barrier function, freely diffuses through the blood and interstitium, and binds to specific widespread receptors, mainly located in cardiovascular and pulmonary tissues.(6, 7) The leading function of ADM is the vasodilatation in both vascular resistance and capacitance vessels resulting in a blood flow increase. ADM further reduce vasoconstriction through an inhibition of the renin-angiotensin-aldosterone Accepted Article system and maintains endothelial integrity reducing vascular permeability.(7) A disruption of ADM system results in vascular leakage that represents the first step of inflammation and of coagulation cascade activation. (8, 9) As derived from ADM in a 1:1 ratio, Mid-Regional proAdrenomedullin (MR-proADM) values directly reflect the effects of its less stable and easily detectable precursor and has been recently introduced in clinical practice as a prognostic marker in patients with bacterial infection. Despite the vast majority of studies evaluated the role of MR-proADM in bacterial infections leading to sepsis, scant evidence is available in patients with viral infections without any information on COVID-19. (12, (14) (15) (16) Knowing that COVID-19 related damage resemble the alteration occurring during sepsis, however, a disruption of ADM pathway during SARS-CoV2 infection may be hypothesized. (8, 9, 17) The aim of this study was to evaluate the role of MR-proADM as a marker of SARS-CoV2 related widespread endothelial damage, clinically identified by organs damage, disease severity and mortality. This article is protected by copyright. All rights reserved.

This study has been approved by the Ethical Committee of the University Campus Bio-Medico of Rome and all patients provided informed consent before the enrollment within the study. This article is protected by copyright. All rights reserved.

Continuous variables were expressed as mean (standard deviation) or median (interquartile ranges), according to data distribution, and were compared using the Student's t-test or the Mann-Whitney U test; categorical variables were expressed as counts and percentages and compared using the Chi square or Fisher's exact tests, as appropriate.

Receiver operating characteristic (ROC) analysis has been performed among independent Kaplan-Meier curves were created to estimate the overall survival and compared using the log-rank test. To evaluate whether the value of MR-proADM influenced mortality rates, a Cox regression model was fitted using age and sex as covariates and the adjusted hazard ratios were calculated.

Data have been analyzed using Med-Calc 11.6.1.0 statistical package (MedCalc Software, Mariakerke, Belgium) and R (version 3.6.3, R Core Development Team, Vienna, Austria). (27) This article is protected by copyright. All rights reserved.

P values < 0.05 were considered statistically significant.

A total of 69 patients has been included in the primary analysis. The main patient characteristics are shown in Table 1 

The best cut-off values for MR-proADM, CRP, ferritin, and PCT in patients with SARS-CoV2 infection were 1.00 nmol/L, 0.48 mg/dL, 115.58 ng/mL, and 0.26 ng/ml, respectively (Supplementary Table 2 ).

Supplementary Table 3 and schematized in Supplementary Figure 1 . AUC value for MR-proADM (0.78) was significantly higher than PCT (0.55; p < 0.0001), smaller than CRP (0.91, p < 0.0001) and similar than ferritin (0.86, p = 0.051). AUC value of CRP was significantly higher than MR-proADM and PCT (p < 0.0001) and similar than ferritin (p = 0.67). Finally, AUC value of ferritin was significantly higher only than PCT (p < 0.0001). Furthermore, the best cut-off for ARDS development prediction were 3.04 nmol/L for MR-proADM, 3.88 mg/dL for CRP, 165.58 ng/mL for ferritin, and 1 for SOFA, respectively. This article is protected by copyright. All rights reserved.

Median values with interquartile ranges and Mann-Whitney's comparison for MR-proADM and SOFA score in survivors and non survivors at 30-day follow-up are reported in Supplementary Table 7. ROC curve and AUC values for MR-proADM and SOFA score resulted statistically significant (p<0.0001) without differences between the variables ( Figure 1B 

The results of this study showed that MR-proADM may be used as a marker of organ damage, disease severity, and mortality in patients with COVID-19. Patients who developed ARDS, the most frequent complication, presented higher MR-proADM values than patients without acute respiratory involvement. Furthermore, MR-proADM values ≥ 2 nmol/L were associated with a significantly higher mortality risk. 

Furthermore, the role of ADM in COVID-19 related organ damage may suggest the use of new therapeutic agents, such as monoclonal antibody. Adrecizumab, a humanized, monoclonal, non-neutralizing ADM-binding antibody has been evaluated in patients with sepsis and acute heart failure in order to improve vascular integrity, tissue congestion, and thereby clinical outcomes. (7, 35) CONCLUSION MR-proADM values ≥ 2 nmol/l identify those patients with high mortality risk related to a multiple organ dysfunction syndrome. These patients must be carefully evaluated and considered for an intensive therapeutic approach. Further studies in larger populations will be warranted to confirm these data.

S.S. led the study design, data collection, data analysis, data interpretation, and manuscript writing; F.E.A., F.S., and F.T. assisted with data collection and analysis of the validation dataset; E.V. and M.F. assisted with computer queries, data analysis and manuscript preparation; F.M. assisted with data collection and analysis of the validation dataset; M.C. assisted with data collection and analysis of the development dataset as well as study design, data interpretation and manuscript writing; S.C. and S.A. assisted with chart review and data analysis and supervised all aspects of the investigation, as well as assisting with study design, data interpretation and manuscript writing. 

The 2019-new coronavirus epidemic: Evidence for virus evolution

Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance

D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

The adrenomedullin receptor acts as clearance receptor in pulmonary circulation

Adrenomedullin in heart failure: pathophysiology and therapeutic application

Adrenomedullin in COVID-19 induced endotheliitis

Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay

How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin

Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections

Procalcitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock

Initial levels of mrproadrenomedullin: a predictor of severity in patients with influenza a virus pneumonia

High plasma mid-regional pro-adrenomedullin levels in children with severe dengue virus infections

The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis -a secondary analysis of a large randomised controlled trial

Antiinflammatory effects of adrenomedullin on acute lung injury induced by Carrageenan in mice

MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination

Procalcitonin and MR-proAdrenomedullin combined score in the diagnosis and prognosis of systemic and localized bacterial infections

Combination with SOFA and qSOFA Scores for Sepsis Diagnosis and Prognosis: A Diagnostic Algorithm

Acute respiratory distress syndrome: the Berlin Definition

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Fourth universal definition of myocardial infarction

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association

Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists

R: A language and environment for statistical computing. R Foundation for Statistical Computing

Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogramming

Risk factors for venous thromboembolism

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis

Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis

Role of Neutrophil Gelatinase-Associated Lipocalin in the Diagnosis and Early Treatment of Acute Kidney Injury in a Case Series of Patients with Acute Decompensated Heart Failure: A Case Series

Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study

Acknowledgments: we thank Stefano Spoto for his help in collecting clinical data.

Funding: none